Dennis J. Selkoe, MD
Co-director, Ann Romney Center for Neurologic Diseases
Chief, Division of Basic Neuroscience Research
Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical School
Dr. Selkoe’s groundbreaking work has identified the fundamental mechanisms underlying the development of Alzheimer's disease (AD), defined forms of amyloid β-protein that have a strong negative effect on neuronal function and on memory, and shown that antibodies to the protein effectively neutralize these adverse effects. His extensive published studies have helped lead to clinical trials of inhibitors of the buildup of the amyloid β-protein, and he is currently examining the detailed basis for neuronal impairment and testing various experimental approaches.
Howard L. Weiner, MD
Co-director, Ann Romney Center for Neurologic Diseases
Chief, Division of Multiple Sclerosis and Neuro-Immunology, Department of Neurology
Robert L. Kroc Professor of Neurology, Harvard Medical School
A world-renowned expert in the treatment and research of multiple sclerosis, Dr. Weiner's discoveries regarding basic mechanisms of MS have led to the development of new treatment approaches applied worldwide. He is the author of Curing MS and the recipient of the prestigious John Dystel Prize from the American Academy of Neurology for his work in MS.
